Pharma Access To Health Ltd

The unique market access resource

07966 586 057

Patient Access Schemes

A frequently used price reduction mechanism by industry. As enshrined in the PPRS (2014) this mechanism enables cost effectiveness to be achieved and positive NICE guidance gained, and therefore mandated baseline NHS funding. This option is considered to be a 'by exception' route to gaining access to positive NICE guidance and is available as a Simple Discount or Standard scheme.

Commercial Access Arrangements and Managed Access Agreements

Guidance and support for these confidential agreements between the industry and NHS England is available. These new options enable access to the market instead of going through the Patient Access Scheme route. Advice to ensure the agreements are fit for implementation within the NHS can be provided.

Local arrangements

Working with industry to reach a balance between the needs of industry and the constraints of the NHS. Through a close working relationship, the opportunities to optimise, standardise and simplify the arrangements across organisations can be achieved, making them the best they can be.


Liaising between the key stakeholders (including industry, NHS and patient groups) by providing subject specific forums, consultation services and client specified meetings. Pharma Access to Health offer these services to enable stakeholders to gain insight and fully understand the whole market perspective, providing opportunities for each to share and learn from the experiences and operating environment of each other.